NCT07134088 · Interventional trial
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia, Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Delaware Valley sites
- Childrens Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory